Literature DB >> 26321256

The role of GRIN2B in Tourette syndrome: Results from a transmission disequilibrium study.

Fengyuan Che1, Ying Zhang2, Guiju Wang3, Xueyuan Heng4, Shiguo Liu5, Yifeng Du6.   

Abstract

BACKGROUND: Previous studies have indicated that dopamine interacts with glutamatergic projection neurons and that N-methyl-d-aspartate (NMDA) receptors might be involved in the pathogenesis of Tourette syndrome (TS). In this study, we examined whether two functional polymorphisms (rs1805476 and rs1805502) in the 3'UTR of the NMDA receptor 2B subunit gene (GRIN2B) were associated with TS in Chinese Han trios.
METHODS: DNA samples collected from 261 TS nuclear families were genotyped by PCR and direct sequencing technology. Haplotype relative risk (HRR), transmission disequilibrium test (TDT) and Haplotype-based haplotype relative risk (HHRR) analyses were performed on the genotype data.
RESULTS: We found an over-transmission of the A allele in rs1805476 and the T allele in rs1805502 from parents to their affected children, using the HRR (rs1805476: HRR=0.696, χ(2)=4.161, P=0.041, 95% CI: 0.491-0.986; rs1805502: HRR=0.697, χ(2)=3.954, P=0.047, 95% CI: 0.488-0.995). There was also strong evidence for a linkage between polymorphisms and TS using the TDT (rs1805476: TDT=5.447, df=1, P=0.024; rs1805502: TDT=5.233, df=1, P=0.027). LIMITATIONS: The sample is small and the current population is just limited to the Chinese Han population.
CONCLUSIONS: These data support the hypothesis that GRIN2B might play a major role in the pathogenesis of TS in Chinese Han trios. However, these results need to be replicated using larger datasets collected from different populations.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Grin2B; HRR; TDT; TS

Mesh:

Substances:

Year:  2015        PMID: 26321256     DOI: 10.1016/j.jad.2015.07.036

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  The association between eating behavior and polymorphisms in GRIN2B, GRIK3, GRIA1 and GRIN1 genes in people with type 2 diabetes mellitus.

Authors:  Olga V Kochetova; Diana S Avzaletdinova; Gulnaz F Korytina; Tatyana V Morugova; Olga E Mustafina
Journal:  Mol Biol Rep       Date:  2020-02-10       Impact factor: 2.316

Review 2.  Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects.

Authors:  Agustina M Lascano; Christian M Korff; Fabienne Picard
Journal:  Mol Syndromol       Date:  2016-07-22

3.  De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.

Authors:  Sébastien Küry; Geeske M van Woerden; Thomas Besnard; Martina Proietti Onori; Xénia Latypova; Meghan C Towne; Megan T Cho; Trine E Prescott; Melissa A Ploeg; Stephan Sanders; Holly A F Stessman; Aurora Pujol; Ben Distel; Laurie A Robak; Jonathan A Bernstein; Anne-Sophie Denommé-Pichon; Gaëtan Lesca; Elizabeth A Sellars; Jonathan Berg; Wilfrid Carré; Øyvind Løvold Busk; Bregje W M van Bon; Jeff L Waugh; Matthew Deardorff; George E Hoganson; Katherine B Bosanko; Diana S Johnson; Tabib Dabir; Øystein Lunde Holla; Ajoy Sarkar; Kristian Tveten; Julitta de Bellescize; Geir J Braathen; Paulien A Terhal; Dorothy K Grange; Arie van Haeringen; Christina Lam; Ghayda Mirzaa; Jennifer Burton; Elizabeth J Bhoj; Jessica Douglas; Avni B Santani; Addie I Nesbitt; Katherine L Helbig; Marisa V Andrews; Amber Begtrup; Sha Tang; Koen L I van Gassen; Jane Juusola; Kimberly Foss; Gregory M Enns; Ute Moog; Katrin Hinderhofer; Nagarajan Paramasivam; Sharyn Lincoln; Brandon H Kusako; Pierre Lindenbaum; Eric Charpentier; Catherine B Nowak; Elouan Cherot; Thomas Simonet; Claudia A L Ruivenkamp; Sihoun Hahn; Catherine A Brownstein; Fan Xia; Sébastien Schmitt; Wallid Deb; Dominique Bonneau; Mathilde Nizon; Delphine Quinquis; Jamel Chelly; Gabrielle Rudolf; Damien Sanlaville; Philippe Parent; Brigitte Gilbert-Dussardier; Annick Toutain; Vernon R Sutton; Jenny Thies; Lisenka E L M Peart-Vissers; Pierre Boisseau; Marie Vincent; Andreas M Grabrucker; Christèle Dubourg; Wen-Hann Tan; Nienke E Verbeek; Martin Granzow; Gijs W E Santen; Jay Shendure; Bertrand Isidor; Laurent Pasquier; Richard Redon; Yaping Yang; Matthew W State; Tjitske Kleefstra; Benjamin Cogné; Slavé Petrovski; Kyle Retterer; Evan E Eichler; Jill A Rosenfeld; Pankaj B Agrawal; Stéphane Bézieau; Sylvie Odent; Ype Elgersma; Sandra Mercier
Journal:  Am J Hum Genet       Date:  2017-11-02       Impact factor: 11.025

4.  Gastrodin Attenuates Tourette Syndrome by Regulating EAATs and NMDA Receptors in the Striatum of Rats.

Authors:  Xueran Sun; Xin Zhang; Keyu Jiang; Min Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-12       Impact factor: 2.570

5.  Jing-an oral liquid alleviates Tourette syndrome via the NMDAR/MAPK/CREB pathway in vivo and in vitro.

Authors:  Leying Xi; Xixi Ji; Wenxiu Ji; Yue'e Yang; Yajie Zhang; Hongyan Long
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 6.  From Genetics to Epigenetics: New Perspectives in Tourette Syndrome Research.

Authors:  Luca Pagliaroli; Borbála Vető; Tamás Arányi; Csaba Barta
Journal:  Front Neurosci       Date:  2016-07-12       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.